Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome

MLA

Eric J. Steenbergen, et al. Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....513054752face96ea395da2f73ec48c8&authtype=sso&custid=ns315887.

APA

Eric J. Steenbergen, Luuk B. Hilbrands, Martijn W.F. van den Hoogen, Sandrine Florquin, & Marije C. Baas. (2017). Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome.

Chicago

Eric J. Steenbergen, Luuk B. Hilbrands, Martijn W.F. van den Hoogen, Sandrine Florquin, and Marije C. Baas. 2017. “Absence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....513054752face96ea395da2f73ec48c8&authtype=sso&custid=ns315887.